diabetestalk.net

Medtronic Insulin Pump 670g

Getting Personal With Medtronic's Minimed 670g

Getting Personal With Medtronic's Minimed 670g

Today, we welcome back Wil Dubois with the second part of his product review of the new Medtronic Minimed 670G, also known as the first Hybrid Closed Loop system ever approved worldwide. This advanced insulin pump-CGM combo received regulatory approval a year ago in September 2016 and has been slowly launching in the U.S. over the past several months. Wil offered his first impressions of the 670G earlier his summer, and has now been on the system long enough to share the Quality of Life impacts he's experienced. Test-Driving the Minimed 670G: Part Two As I boxed up my Medtronic 670G at the end of my three-month trial, a wave of relief swept over me. This took me by surprise, as I’ve always been a pump lover and had been chomping at the bit to try this new device -- the pinnacle of all that we tech-savvy T1s have been clamoring for -- since I'd first read about it. But in the course of using it, I experienced a shift not only in how I felt about the 670G, but about the invasiveness of insulin pumps in general for the first time ever. To dig into the story of what happened, we have to start at the very beginning with a refresher on the system basics. Medtronic 670G Basics Officially known as a "Hybrid Closed Loop" because it only does some of the diabetes thinking for you and leaves the rest in the user's hands, the 670G is the first of its kind and is by most accounts an early generation of an Artificial Pancreas system. It has three modes: Auto, Safe, and Manual. Manual mode: In this mode, the 670G functions as pretty much a garden-variety pump, albeit a nice one. It uses basal rates set by the user and his or her medical team, has variable insulin-to-carb ratios and correction factors, allows for dual and square wave boli and temporary basal rates, and has a low susp Continue reading >>

Insulin Pump System

Insulin Pump System

References * Mean Absolute Relative Difference. ** 3-4 calibrations per day required. 1. Bailey T, et al. Accuracy, Precision, and User Performance Evaluation of the CONTOUR®NEXT LINK 2.4 Blood Glucose Monitoring System. Poster presented at the 7th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD); 2014 February 5–8, Vienna, Austria. Important Safety Information: MiniMed® 670G System The Medtronic MiniMed 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, fourteen years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 670G system includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system requires a prescription. The Guardian Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. All therapy adjustments should be based on measurements obtained using the CONTOUR®NEXT LINK 2.4 blood glucose meter and not on values provided by the Guardian Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NE Continue reading >>

Medtronic Minimed 670g Pump Can Predict And Help Prevent Insulin Swings | Miami Herald

Medtronic Minimed 670g Pump Can Predict And Help Prevent Insulin Swings | Miami Herald

If the monitor indicates that my levels are too low, I will drink a Gatorade, he said. If its too high, I just hit OK. Either way, Smith has to prick his finger something he does four or five times a day anyway to make sure his blood-sugar level has been corrected. Smith said the Medtronic pump represents a game-changer in his life. My blood-sugar levels are much more consistent and stable as compared to before, Smith said. Now its so much easier to get dialed in my levels are almost always in range, and I feel better. Dr. Miladys Palau, a pediatric endocrinologist at Nicklaus Childrens, was among the first doctors to study the device as part of her fellowship at the Yale School of Medicine. Palau said the Medtronic pump works by automatically measuring blood sugar, predicting when a rise or fall is going to occur and adjusting itself to deliver precise doses of background insulin, requiring minimal interaction from the patient. It is available to patients 14 or older, and children ages 8-13 can use it depending on the discretion of the attending physician, she noted. Just like with any other pump, the patient can have a reaction, Palau said. But the pros far outweigh the cons. This is the only pump on the market that is able to communicate with the sensors. The device checks a patients blood sugar every five minutes, and the sensor sends information to the pump. The system calculates the rate of change and how much insulin if any is needed. If you are doing what the pump is telling you to do, Palau said, it works extremely well. The system is unique to each person because it learns the trends in the users blood-sugar levels. The more you use it, the better it works, Colton said. I feel completely safe and at peace with this pump. Continue reading >>

Minimed 670g System - P160017/s017

Minimed 670g System - P160017/s017

This is a brief overview of information related to FDA's approval to market this product. See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for the FDA's approval. Address: 18000 Devonshire Street, Northridge, CA, 91325 What is it? The MiniMed 670G System is a hybrid closed loop system that monitors glucose and automatically adjusts the delivery of long acting or basal insulin based on the user's glucose reading. This device was approved on September 28, 2016 under P160017. The current approval adds a new indication to insert the sensor into the patient's upper arm. How does it work? The MiniMed 670G System consists of a continuous glucose monitor (CGM) that measures the user's glucose levels for up to seven days, an insulin pump that delivers insulin to the user, and a glucose meter used to calibrate the CGM. The MiniMed 670G System is able to decrease or stop insulin delivery when it detects the user's glucose is low, or increase the insulin delivery when the system detects the user's glucose levels are high with no input from the user. The glucose sensor contains a wire that is inserted under the skin on the abdomen or, as approved in this supplement, the upper arm. The glucose sensor measures glucose values in the tissue fluid. The glucose values are wirelessly sent to the insulin pump, and displayed along with glucose trend information, alerts, and alarms on the pump screen. The insulin pump delivers a prescribed dosage of insulin through an infusion set. The insulin pump can automatically adjust the delivery of insulin using a mathematical equation, or algorithm that incorporates information from the CGM. The system has two modes; Ma Continue reading >>

A Nurses Review: Medtronic 670g Insulin Pump

A Nurses Review: Medtronic 670g Insulin Pump

Medtronic’s 670 G hybrid closed loop system is the smartest insulin pump to hit the market, and people living with type 1 diabetes, including my daughter and I, have been gobbling them up. As we embark into our second week on this new system, the majority of the time I’m all in, thinking: “This is amazing, I haven’t drank juice in days,” “I need to eat something – just to eat, not because I need to balance my diabetes,” “It’s so nice not to have T1D awaken me from sleep,” or “I feel less worried about my daughter.” All remarkable thoughts. A minority of the time, I’m thinking: “Why is this pump buzzing at me again?” “This algorithm isn’t really getting me into the 120 range,” “This sensor is frustrating – my Dexcom was so simplistic to use compared to this finicky Guardian 3 sensor,” “I wish I could calibrate anytime; there’s so much button pushing and user demand.” It’s not all peaches and cream – it’s a work in progress. Patience, I tell myself. It will get to know me better. Most people report that it takes a month to love the Medtronic 670G. Truth be told: I’m one week in, and I do love it 90% of the time – as does my 15 year old. Getting Started on the 670G We personally utilized the “Pathway Program” Medtronic offered through the end of April, 2017, placing us in a virtual line for the Medtronic 670G upgrade. We were fortunate enough to have purchased our pumps less than a year prior, so our out of pocket was expensive, but not unthinkable. Word has it that 50,000 customers have ordered the Medtronic 670G pump, but customers have faced hurdles along the way with the age of their current pumps and/or lack of insurance coverage for a new pump. Owning a pump that isn’t out of warranty means we’re at Continue reading >>

Hybrid Closed Loop System.

Hybrid Closed Loop System.

NEW! The Suspend before low§ option avoids lows and rebound highs proactively by automatically stopping insulin 30 minutes before you reach your pre-selected low limits, then automatically restarts insulin when your levels recover, all without bothersome alerts. NEW! The Auto Mode‡ option automatically adjusts your basal insulin delivery every 5 minutes based on your sugar levels to keep you in target range, all day and night. Watch Video View Brochure Get Started NEW! Guardian® Sensor 3 continuous glucose monitoring sensor. Introducing the most accurate sensor from Medtronic, now with up to 7 day wear and easy insertion. It is the FIRST and ONLY continuous glucose monitoring sensor FDA approved and trusted to control insulin dosing. Exclusive CONTOUR®NEXT LINK 2.4 meter1 Get easy and accurate CGM calibration, insulin dosing and remote bolusing with our exclusive meter. “This device will mean peace of mind, in knowing a person will be in normal blood sugar range a great majority of the time,” “It’s a medical device with the potential to change the lives of more than 1 million Americans who suffer from Type 1 diabetes.” KEEP YOUR GLUCOSE IN RANGE SMARTGUARD® HCL TECHNOLOGY. Quick and easy access to your glucose and insulin information, all from the home screen. Bright color screen for easy readability - day or night. Waterproof - so you can enjoy underwater activities. Quick and easy bolus from your meter. Fewer shots than multiple daily injections. The only sensor FDA approved and trusted to control insulin dosing. Easy to insert. Know at all times where your glucose levels are trending. Click here for assistance if your insurance does not currently cover the MiniMed 670G system. * Mean Absolute Relative Difference. ** 3-4 calibrations per day required. Continue reading >>

Medtronic Minimed 670g Help For Diabetics Needing Insulin

Medtronic Minimed 670g Help For Diabetics Needing Insulin

There are an estimated 86 million diabetics in the U.S. Of those, about 3 million have Type I Diabetes, a disease in which the body produces none of its own insulin. And millions of the Type II diabetics are on a full-insulin replacement. They spend countless hours injecting themselves and pricking their fingers to check their blood sugar, often chasing what can seem like an endless loop of highs and lows. Now theres at least a partial solution. Officially, its the Medtronic MiniMed 670G . Unofficially its been called the artificial pancreas (a name the American Diabetes Association and Medtronic would prefer you didnt use since it overstates the systems capabilities). Medtronic bills it as the worlds first hybrid closed loopsystem; the first [and so far only FDA approved] system that constantly self-adjusts to automatically keep glucose levels in target range. The two major components of the MiniMed System, the insulin pump and thecontinuous glucose monitor (CGM) are not new. The first wearable insulin pump was invented by Dean Kamen back in 1973 and came to market three years later. The first practical CGM came from MiniMed (later purchased by Medtronic) in 1999. So why has it taken so long to get these two devices to work with each other? The short answer is technology. Putting the two of them together required the development of complex algorithms that just didnt exist before, and a microprocessor-based platform capable of making the connection. You can read some of the development history here . First approved by the FDA in the fall of 2016, Medtronic brought it to market in spring of 2017. The launch has been so successful it has brought on growing pains for the company in terms of production and customer service (more on that later). It was aimed at Type I diabe Continue reading >>

Pros & Cons Of The Medtronic Minimed 670g With Guardian

Pros & Cons Of The Medtronic Minimed 670g With Guardian

Our 2018 review Unique Advantages: Pros Large, secure, long-established company Industry leader in R & D Data from Medtronic Guardian CGM displayed on-screen Automatic basal shutoff when low glucose detected by sensor (may help prevent severe hypos) Hybrid closed loop(Automode) basal adjustment based on CGM readings and predictive algorithms High-contrast full-color screen Slim attachable clip Integrated meter serves as remote control for bolusing Frequently used boluses & temp basals can be stored as “presets” Downloadable to online Carelink program Choice of slow or fast bolus delivery Generates insulin/carb/BG statistics “Airplane Mode” option CGM and Automode require additional finger sticks for calibration and safety checks. Maintaining Automode requires a higher level of technical acumen and interaction with the pump. Frequent system alerts in Automode may become intrusive Attached clip is upside-down Must pay for loaner/backup pumps Screen and text are relatively small Insulin-on-board only deducted from correction boluses Downloading restricted to Carelink program Multiple menus and programming can be complex to master Many button-presses and confirmation steps in basic programming Sensor supplies currently on back order until Spring 2018 Delay in getting pumps, supplies and training to new users Company’s marketing can be overly aggressive Continue reading >>

Medtronic Puts Insulin Needle Out Of Sight, Out Of Mind

Medtronic Puts Insulin Needle Out Of Sight, Out Of Mind

Medtronic Puts Insulin Needle Out of Sight, Out of Mind The latest version of Medtronic's MiniMed Mio insulin infusion set uses a concealed needle so that users no longer have to see or come into contact with their insertion set needle. Medtronic's MiniMed 670g insulin pump system, which operates as a hybrid closed-loop system for insulin delivery, received earlier-than-expected FDA approval in 2016. Now the company has released an updated version of the system, the MiniMed Mio Advance, which is designed to make it easier for users to change infusion sets. Medtronic has launched the latest version of its MiniMed Mio insulin infusion set in Canada, Hong Kong and parts of Europe. The MiniMed Mio Advance is an update of the MiniMed Mio, introduced in 2010 and designed to deliver insulin from an insulin pump to the body. The Mio Advance should make changing infusion sets quicker and easier, according to the company. Diabetic patients who use insulin pumps generally change their infusion set every two or three days, selecting different insertion sites to prevent skin breakdown and maximize insulin absorption. Thin plastic tubing included in the set comes in varying lengths to reach different sites, such as the abdomen, thigh or buttock. The Mio Advance uses a concealed needle to insert a cannula -- a small, tapered tube at the end of the infusion set tube -- under the skin to deliver insulin. The cannula remains and delivers the insulin from the pump, explained Danielle Swanson, spokeswoman for the Medtronic Diabetes Group in an email to MD+DI Qmed. With no exposed needle at any point during insertion, users no longer have to see or come into contact with their insertion set needle. The Mio Advance has a pre-loaded, disposable, single-use inserter that enables patients to c Continue reading >>

670g And Me: Insights And Incites On Medtronic’s Latest System

670g And Me: Insights And Incites On Medtronic’s Latest System

What’s the purpose of a diabetes management device? Is it to lower A1c? Prevent hypoglycemia? Spend more time in-range? Some combination of all three? Or perhaps we have to look beyond blood sugar control. After all, quality of life has to count for something. Does it make living with diabetes safer and easier? My Detailed Review of The MiniMed 670G from Medtronic The MiniMed 670G from Medtronic is an insulin pump coupled with a glucose sensor. It uses a computer program (called an “algorithm”) to automate certain aspects of insulin delivery. I decided to try 670G partially out of professional interest (everybody and their great aunt has been asking for my opinion on the system), and partially out of personal interest, as my blood glucose control hasn’t been the greatest the past couple of years. Let me start out by saying this: Since I started using 670G, my overall blood glucose control is better. I have to keep reminding myself of this non-consequential fact, because every day I find things about this system that I don’t particularly like. In my opinion, the pump itself leaves a lot to be desired. There are so many features and so many menus and so many safety/confirmation steps that my button thumb is starting to form a blister. The color screen is nice, but not large enough to display everything it needs to display. And the freakin’ clip is upside down. The reservoir connector pokes me in the gut every time I bend over, and I have to unclip it to see the screen and programming menus in the proper orientation. The “hybrid closed loop” part of the system (what I prefer to call the “semi-automatic feature”) is what makes 670G special. It functions by making adjustments to the BASAL insulin based on data received from the linked glucose sensor. Sinc Continue reading >>

What It’s Like To Use The Medtronic 670g

What It’s Like To Use The Medtronic 670g

Jason Gensler, person with type 1 diabetes, is the founder of the Foundation for Type One Diabetes and the creator of the synergistic philanthropy model. He’s an out of the box thinker, beer aficionado, coffee connoisseur, and bacon fanatic. He proudly dedicates his life to social entrepreneurship on behalf of the global type 1 diabetes community. Jason is one of the first users of the Medtronic 670G hybrid closed loop insulin pump system, sometimes referred to as an artificial pancreas. He’s been wearing the pump for the last 23 months and is planning to help test the next iteration of Medtronic’s technology. He answered some questions for us about what it’s like to live with this promising new device. Tell us a bit about yourself and your experience with diabetes. How old were you when you were diagnosed with type 1 diabetes, and how did you manage your blood sugars before you started the 670G? I was diagnosed with T1D two weeks after my 16th birthday. My 17 year Dia-versary is on May 10th 2017. Prior to the 670G I was wearing the T-slim pump and using the Dexcom G4 CGM. I managed my BGs as best I could prior to the trial and although I could maintain about a 7.0% – 8.0% A1C it felt like a ton of work. What inspired you to sign up to try the 670G? I have participated in many trials over the last 5 years at the Barbara Davis Center, and have witnessed the progress being made in our industry. I went into the 670G pivotal trial with huge expectations, knowing what was on the line for the diabetes industry, our T1D community, and knowing how many companies are pursuing their own version of an artificial pancreas or ‘automated system’. I applaud Medtronic for their efforts to blaze the trail for the industry. In my opinion, they learned a great deal from the Continue reading >>

Medtronic Minimed 670g System Review

Medtronic Minimed 670g System Review

After months of waiting, I finally received the world’s first hybrid closed loop system, the Minimed 670G system. Medtronic’s Minimed 670G system is an insulin pump and continuous glucose monitor that also has technology to put you in “auto” mode where it will automatically adjust your basal insulin every 5 minutes based on your blood sugar levels. I’ve had the system for about two weeks now so I thought I’d share my thoughts on it. I’m going to break this down into two posts because I feel the auto mode review needs it’s on page. I’ve been with Medtronic and on an insulin pump since 1997, 20 years! For most of the 20 years, the insulin pump has looked the exact same. It has “mainly” had the same features and not a lot of technology advancements. This new pump, however, is completely different than anything Medtronic has released in the last 20 years, with one caveat that they did release the Minimed 630G a few months prior. I received the Minimed 630G as part of the Minimed 670G Priority Access Group. In case you weren’t aware, Medtronic released a new pump, the 630G, last year and a few weeks (or months, not positive on the timing), the FDA approved their 670G pump faster than they realized. To not waste all the millions of dollars they probably spent on the 630G, they started a Priority Access Group for the 670G where you had to get the 630G first and then once the 670G was released, you could be the first to get it. The stars aligned for me where my pump went out of warranty last year and I had reached my out of pocket max because of the birth of my baby, so I was able to get the 630G for free! I never did use the 630G though because the new design of the pump sort of scared me and I was happy with my old pump. Because I never used the 630G, Continue reading >>

Why I Won't Be Switching To Medtronic's 670g Insulin Delivery System Billed As The First Artificial Pancreas - Medcity News

Why I Won't Be Switching To Medtronic's 670g Insulin Delivery System Billed As The First Artificial Pancreas - Medcity News

5 Comments / Feb 26, 2018 at 5:32 PM When Medtronic won approval for the MiniMed 670G from the FDA in 2016 , it was a big deal. Advertised as The Worlds First Hybrid Closed Loop System, it is the first commercial product of its kind able to automate insulin delivery and requiring lesser patient input than in the past. However, after reading more about the specifics, and having heard more first-hand accounts, I can now safely say that I am somewhat underwhelmed. When evaluating the 670G I was exclusively looking at the features of the auto mode in comparison to the system I use now. That is the OpenAPS, which is an open source artificial pancreas solution built using an Intel Edison (tiny computer) and a Medtronic insulin pump. My initial thought was that it might be nice to use a commercial solution instead of an open source one if it could make my daily life easier (there are elements of using an open source solution that are tiring at best). Here I lay out the reasons that drove my decision to stick with what I have instead of switching to Medtronics CGM. It should be noted, however, there is no one-size-fits-all solution for insulin-dependent diabetics. Ultimately, its a personal choice. What its really doing, not just what the basal rate has been adjusted to, but how the system got to that decision. Its not that I always read the exact calculations of the OpenAPS algorithm, but I could because I can access my live information at any time. I can access not just my blood glucose (BG) and basal insulin rate, but also the actual numbers and calculations going into the recommendations and changes that the system is making. No personalized targets for blood glucose levels The system targets 120 all of the time. The only other option is a temp target of 150 meant for exer Continue reading >>

Medtronic Minimed® 670g Insulin Pump System

Medtronic Minimed® 670g Insulin Pump System

The MiniMed® 670G Insulin Pump System is the first hybrid closed loop (HCL) system. This system offers the most advanced SmartGuard® HCL technology, with two new levels of personalization. Manual Mode with the Suspend Before Low feature automatically stops insulin 30 minutes before pre-selected low limits, then restarts once insulin levels recover. Auto Mode continuously reads sensor glucose values and automatically adjusts basal insulin every 5 minutes. Guardian Sensor® 3 provides up to 7 days of wear Waterproof design with user-friendly color screen and simple menu Built-in CGM allows for wireless transmittal of glucose information every five minutes Bolus Wizard® makes it easier to calculate mealtime insulin and may avoid insulin stacking CCS Medical offers Ascensia Diabetes Care strips for use with Medtronic pumps for many insurance plans. Continue reading >>

The Minimed 670g Automatic Glucose Monitor And Insulin Pump For Diabetes

The Minimed 670g Automatic Glucose Monitor And Insulin Pump For Diabetes

Brand name: Minimed 670G System Device Generic Name: Automated Insulin Delivery System Device class: Insulin Pump Manufacturer: Medtronic FDA Approval date: September 28, 2016 On September 28th, 2016, the US Food and Drug Administration approved MiniMed 670G by Medtronic. It is the first FDA-approved device that automatically monitors glucose levels while providing an appropriate basal insulin dose in type 1 diabetics older than 14 years. What is the MiniMed 670G used to treat? MiniMed 670G is a hybrid closed looped system approved by the FDA to treat type 1 diabetes patients ages 14 years or older who require greater than 8 units of basal insulin per day. What is Minimed 670G and how does it work? MiniMed 670G has an integrated SmartGuard technology with an advanced algorithm to simplify and improve diabetes management. It enables greater glucose control with reduced user input. The system includes: the glucose sensor and continuous glucose monitor (CGM) that measures the user’s glucose levels for up to seven days, an insulin pump that delivers insulin, and a glucose meter used for calibration The glucose sensor is inserted under the skin of the abdomen and it measures glucose values in the tissue fluid. The sensor measures blood glucose levels every 5 minutes (interval depends on settings) and the insulin pump automatically administers or withholds basal insulin depending on blood glucose levels and user selected insulin dosing rates. If the glucose level is higher than the preset normal range, then insulin will be delivered following the algorithm. If the glucose level is lower than the preset normal range, the device will withhold insulin administration. Although the device works automatically, the user can also` administer insulin manually to adjust for meals. Th Continue reading >>

More in diabetes